Allergan, Adamas settle patent lawsuit with Amneal

(Reuters) - Allergan Plc said it and Adamas Pharmaceuticals Inc settled a patent infringement lawsuit with Amneal Pharmaceuticals over their Alzheimer’s drug. Allergan said its

Forest Labs unit and Adamas had filed a lawsuit against privately owned Amneal, which was seeking regulatory approval f

or generic versions of Namza2020第87期跑狗解狗图 ric. The drug, which has been licensed to Forest by Adamas, had U.S. sales of $

12.8 million for the quarter end

ed June 30. Under the settlement terms, Forest and Adamas will grant Amneal a licens

e to market generic versions of Namza

ric from January 1, 2025. Other 


rms of the settlement were not disclosed. Allergan and Adamas have also sued Amerigen Pharmaceuticals, whic

h seeks to market generic versions of the drug.